About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
The biopharmaceutical industry uses its scientific and technical expertise to research, develop, manufacture and distribute safe and effective treatments and vaccines to patients around the world. The intellectual property (IP) system enables this investment and supports competition. Regulatory data protection (RDP) is a critical element of effective IP systems and is a critical component of international IP rules.
Regulatory Data Protection Promotes Biopharmaceutical Innovation and Patient Access image
Fact Sheet
Intellectual Property
Regulatory Data Protection Promotes Biopharmaceutical Innovation and Patient Access
Regulatory Data Protection Promotes Biopharmaceutical Innovation and Patient Access image